Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
NCT07502443
- Conditions
- Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +7 more
- Locations
-
- Alkermes Investigational Site Cullman, Alabama, United States
- Alkermes Investigational Site Los Angeles, California, United States
- Alkermes Investigational Site Boulder, Colorado, United States
- Alkermes Investigational Site Brandon, Florida, United States